clover therapeutics is now character biosciences

we're for people

Character is a precision medicine platform that is unlocking the patterns of age-related diseases in people of diverse backgrounds. Our mission is to use human genetics to understand what drives diseases so we can discover targeted therapies to more effectively treat patients - many of whom lack any treatment options today.

age-related diseases
are not monolithic

For the last century, most diseases have been treated as monolithic and homogenous with very little granularity.

we're unlocking the
patterns of disease

The truth, as we see in our work every day, is that diseases are as diverse as the patients they impact. That’s why we are building world-class clinical genomic databases to characterize the diversity of biological pathways driving disease progression and to develop pathway-specific precision medicine.

age-related diseases
are not monolithic

For the last century, most diseases have been treated as monolithic and homogenous with very little granularity.

we're unlocking the
patterns of disease

The truth, as we see in our work every day, is that diseases are as diverse as the patients they impact. That’s why we are building world-class clinical genomic databases to characterize the diversity of biological pathways driving disease progression and to develop pathway-specific precision medicine.

revealing the nuances in
disease progression

Character partners with patients, providers, payers, and scientists to create large deeply phenotyped patient cohorts to enable clinical genomic research. Our approach integrates genomics, longitudinal clinical and imaging data, machine learning, and novel experimental approaches to discover innovative disease-modifying treatments.

Patient
Network
Longitudinal
disease progression
Full-stack, curated clinical database of imaging, EMR, claims, and lab data
Integrated
multi-omics
Genomics and other omics to characterize diseases at the molecular level
Machine learning
phenotyping
Advanced machine learning to quantify phenotypes of disease progression
In-house drug and diagnostic pipeline
Novel therapeutics
and complementary
diagnostics

the character precision medicine discovery platform

Our clinical genomic and deep phenotyping platform powers novel drug and diagnostic discoveries.

Hover over left image for more.

Tap the image above for more.

Volumetric OCT: Dry age-related macular degeneration
Fundus autofluorescence: Dry age-related macular degeneration

our programs

Research
Pre-clinical
Clinical
Therapeutic indication
Research
Pre-clinical
Clinical

1. Age-related macular degeneration (AMD)

2. Glaucoma

3. Announcing soon

let's solve age-related diseases together

Provider Partnerships

By working with the best healthcare providers, we are determined to understand how diseases behave in real life and tackle the largest unmet needs.

Patient Research

As a patient, you have an opportunity to contribute to research that could deliver better treatments for you and others like you in the future.